Sibutramine - Abbvie
Alternative Names: Aoquqing; BTS 54524; Ectiva; KES 524; Meridia; Reductase; Reductil; Reduxade; SibutralLatest Information Update: 05 Nov 2023
At a glance
- Originator Abbott GmbH & Co. KG
- Developer Abbott GmbH & Co. KG; AstraZeneca; Eisai Co Ltd; Il Sung; Nanjing Chang'ao Pharmaceutical
- Class Anorectics; Cyclobutanes; Obesity therapies
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Obesity
- Discontinued Major depressive disorder